Renaissance Technologies’s Enzon Pharmaceuticals ENZN Stock Holding History
Bought
Maintained
Sold
Other funds holding ENZN
Renaissance Technologies's ENZN Position: Q2 2016 in Review
Renaissance Technologies sold out of Enzon Pharmaceuticals (ENZN) in Q2 2016, closing a stake of 3,143,585 shares — an estimated $1.48M sold.
Renaissance Technologies first reported a position in ENZN in Q2 2013 and held it in 12 quarters. The position peaked at $4.34M in Q2 2015. 10 funds tracked by Wall St. Rank hold ENZN as of Q2 2016.
- Renaissance Technologies reported no remaining Enzon Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
- Renaissance Technologies sold 3,143,585 Enzon Pharmaceuticals shares in Q2 2016, an estimated $1.48M.
- Renaissance Technologies first reported a position in Enzon Pharmaceuticals in Q2 2013 and held it in 12 quarters.
- Renaissance Technologies's Enzon Pharmaceuticals position peaked at $4.34M in Q2 2015.
- 10 funds tracked by Wall St. Rank held Enzon Pharmaceuticals as of Q2 2016.
Based on Renaissance Technologies's 13F filing for Q2 2016, filed 12 Aug 2016.